A detailed history of Morgan Stanley transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,292,068 shares of TMCI stock, worth $21.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,292,068
Previous 3,117,734 5.59%
Holding current value
$21.9 Million
Previous $39.8 Million 8.08%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.48 - $15.86 $2 Million - $2.76 Million
174,334 Added 5.59%
3,292,068 $43 Million
Q4 2023

Feb 13, 2024

BUY
$6.03 - $12.88 $17.5 Million - $37.4 Million
2,904,228 Added 1360.26%
3,117,734 $39.8 Million
Q3 2023

Nov 15, 2023

SELL
$12.16 - $24.87 $2.81 Million - $5.75 Million
-231,152 Reduced 51.98%
213,506 $2.8 Million
Q2 2023

Aug 14, 2023

BUY
$23.91 - $27.81 $668,141 - $777,122
27,944 Added 6.71%
444,658 $11.4 Million
Q1 2023

May 15, 2023

BUY
$20.23 - $26.22 $4.72 Million - $6.12 Million
233,531 Added 127.49%
416,714 $10.5 Million
Q4 2022

Feb 14, 2023

BUY
$20.54 - $24.67 $1.94 Million - $2.33 Million
94,320 Added 106.14%
183,183 $4.21 Million
Q3 2022

Nov 14, 2022

BUY
$14.71 - $24.18 $731,057 - $1.2 Million
49,698 Added 126.89%
88,863 $1.96 Million
Q2 2022

Oct 27, 2022

BUY
$12.93 - $20.29 $244,092 - $383,034
18,878 Added 93.05%
39,165 $560,000
Q2 2022

Aug 15, 2022

BUY
$12.93 - $20.29 $244,092 - $383,034
18,878 Added 93.05%
39,165 $560,000
Q1 2022

Oct 27, 2022

SELL
$16.73 - $21.58 $315,828 - $407,387
-18,878 Reduced 48.2%
20,287 $384,000
Q1 2022

May 13, 2022

SELL
$16.73 - $21.58 $401,486 - $517,876
-23,998 Reduced 54.19%
20,287 $384,000
Q4 2021

Feb 14, 2022

BUY
$15.48 - $26.52 $629,649 - $1.08 Million
40,675 Added 1126.73%
44,285 $826,000
Q3 2021

Nov 15, 2021

BUY
$24.15 - $30.5 $87,181 - $110,105
3,610 New
3,610 $97,000

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $368M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.